Ignite Creation Date:
2025-12-25 @ 4:04 AM
Ignite Modification Date:
2025-12-26 @ 2:59 AM
Study NCT ID:
NCT00184002
Status:
COMPLETED
Last Update Posted:
2017-08-10
First Post:
2005-09-12
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Doxorubicin (Doxil) Combined With Rituxan, Cyclophosphamide, Vincristine and Prednisone in Newly Diagnosed Aggressive Non-Hodgkin's Lymphomas
Sponsor:
University of Southern California
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2003-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2012-12-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-05-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-12
First Submit QC Date:
None
Study First Post Date:
2005-09-16
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-07-13
Results First Submit QC Date:
None
Results First Post Date:
2017-08-10
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-07-13
Last Update Post Date:
2017-08-10
Last Update Post Date Type:
ACTUAL